Skip to main content

Longeveron Inc.

LGVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001721484

No open-market purchases or sales by Longeveron Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $3.35M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Longeveron Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of LGVN: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders1012+2
Shares85.2K363.8K+278.6K (+327.1%)
Value$561.0K$2.96M+$2.40M (+427.5%)

New holders (5)

Institutions that held Longeveron Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to LGVN in Q2 2021
InstitutionSharesValue% of portfolio
Pura Vida Investments, LLC67,120$546.0K0.04%
Renaissance Technologies LLC38,200$311.0K0.00%
Geode Capital Management, LLC14,788$120.0K0.00%
Janney Montgomery Scott LLC14,000$114.0K0.00%
Royal Bank of Canada3,500$28.0K0.00%

Sold out (3)

Institutions that held Longeveron Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of LGVN in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Two Sigma Investments, LP13,100$86.0K
Tower Research Capital LLC (TRC)4,876$32.0K
Total Clarity Wealth Management, Inc.1,000$7.00K